Immunomodulatory aspects in the progression and treatment of oral malignancy

• Κύριοι συγγραφείς: Nobuo Kondoh (Συγγραφέας), Masako Mizuno-Kamiya (Συγγραφέας), Naoki Umemura (Συγγραφέας), Eiji Takayama (Συγγραφέας), Harumi Kawaki (Συγγραφέας), Kenji Mitsudo (Συγγραφέας), Yasunori Muramatsu (Συγγραφέας), Shinichiro Sumitomo (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2019-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Inflammation substantially affects the risk of oral malignancy. Pro-inflammatory cytokine, interferon (IFN)-γ, confers anti-tumor activity using several different mechanisms. Conversely, higher expression of interleukin (IL)-17 is associated with worse prognosis. Monocyte chemotactic protein (MCP)-1...